PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
HumanaMedicare Advantage · Prior Auth · Medicare Advantage · Endocrinology, Family Medicine, Internal Medicine +1 moreMedium impact

DPP-IV, SGLT2 Combination Products (Revised)

Act
by Jan 1, 2026
Effective date
Jan 1, 2026
Identified
Jun 24, 2026

Summary

Humana Medicare Advantage now requires prior authorization for DPP-IV/SGLT2 combination diabetes medications (Steglujan, Qtern, and generic dapagliflozin-saxagliptin) effective January 1, 2026. Patients must have tried individual DPP-4 or SGLT2 inhibitors first, or have contraindications to them.

Get alerts when payers change rules like this one

We check Humana and other payers every day and email you when a change matches your specialty and state.

Get Humana alertsPolicy Monitoring is free. No card required.

What to do

by Jan 1, 2026 · 3 steps
01Billing team must update prior authorization system to require preapproval for Steglujan, Qtern, and dapagliflozin-saxagliptin tablets for Humana Medicare Advantage patients.
02Providers must document previous treatment with or contraindications to individual DPP-4 inhibitors (sitagliptin, linagliptin) or SGLT2 inhibitors (empagliflozin, dapagliflozin) before prescribing combination products.
03Update EMR templates to include diabetes medication history documentation.

Original notice

DPP-IV, SGLT2 Combination Products (Revised)
mcp.humana.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account